Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsy

3 Apr 2025

Abstract excerpt

Liquid biopsies, which analyze circulating tumor cells or cell-free circulating tumor DNA (ctDNA) from blood, have emerged as promising cancer detection and monitoring tools. Specifically, human papillomavirus (HPV) cell-free (cf) DNA is gaining recognition as a prognostic marker in high-risk HPV-related cancers. However, detecting circulating markers for cervical cancer (CC) requires highly sensitive techniques...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cervical Cancer and HPV Research
Share to Molecular Biology Techniques and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40180979
DOI: 10.1038/s41598-025-93152-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsyPMID 40180979Read ↗

Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancerSemantic proximity Read ↗

Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancerSemantic proximity Read ↗

Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapseSemantic proximity Read ↗

The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV ‐associated tumors: A reviewSemantic proximity Read ↗

Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and MonitoringSemantic proximity Read ↗

Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical CancerSemantic proximity Read ↗

Sensitive and Specific Droplet Digital PCR Assays for Circulating Tumor HPV DNA: Development, Validation, and Clinical Application in HPV-Associated Cancers.Semantic proximity Read ↗

Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarkerSemantic proximity Read ↗

Liquid Biopsy of HPV Cell-Free DNA Enables Blood-Based Early Detection and Molecular Stratification of HPV-Associated Cancer and Precancer StagesSemantic proximity Read ↗

Liquid Biopsies with Circulating Plasma HPV–DNA Measurements—A Clinically Applicable Surveillance Tool for Patients with HPV-Positive Oropharyngeal CancerSemantic proximity Read ↗

Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancerSemantic proximity Read ↗

Detection, quantitation, and genotyping of human papillomavirus circulating tumor DNA by droplet digital PCR.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.